-
Actress Marisa Tomei partners with allergan to raise awareness of chronic dry eye
Jul 28, 2016News Hour: Actress Marisa Tomei announced that she is partnering with Allergan plc (NYSE: AGN) to raise awareness and educate consumers about Chronic Dry Eye disease (CDE). Tomei was recently diagnosed with a type of CDE... -
Allergan receives positive opinion for truberzi® (eluxadoline) for treatment of irritable bowel syndrome with diarrhoea (ibs-d) in adults
Jul 28, 2016News Hour: Allergan plc (NYSE: AGN), a leading global pharmaceutical company,announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive Opinion for TRUBERZI® (eluxadoline) in the European Union.TRUBERZI® is an oral... -
First patient treated in phase 3 studies and positive Phase 2 results of roxadustat in patients with chronic kidney disease in Japan
Jul 28, 2016News Hour: Astellas Pharma Inc. (TSE:4503, “Astellas”) and FibroGen, Inc. (“FibroGen”), announced the dosing of the first patient in Phase 3 trials in Japan of roxadustat (development code: ASP1517/FG-4592) for treatment of anemia in chronic kidney... -
Cytokinetics and Astellas announce option right for tirasemtiv and expansion of global collaboration for ck-2127107 in als
Jul 28, 2016News Hour: Cytokinetics, Inc. (Nasdaq: CYTK, “Cytokinetics”) and Astellas Pharma Inc. (TSE: 4503, “Astellas”) announced that Cytokinetics and Astellas have expanded their collaboration in skeletal muscle activators to include amyotrophic lateral sclerosis (ALS). Through this expansion,... -
Astellas named to ftse4good sustainability index for the fifth consecutive year
Jul 28, 2016News Hour: Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) announced that it has been selected for the fifth consecutive year to be included in the FTSE4Good Index Series, one of the world’s premier indices... -
The university of Tokyo and Astellas enter into a new collaborative development agreement for rice-based oral vaccine
Jul 28, 2016News Hour: The Institute of Medical Science, the University of Tokyo (Tokyo, Dean: Yoshinori Murakami, “IMSUT”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) announced that they have signed a new collaborative... -
Astellas and medivation initiate Phase III trial of enzalutamide in patients with triple-negative breast cancer
Jul 28, 2016News Hour: Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc. (NASDAQ: MDVN) announced plans to commence a Phase III clinical trial to investigate the use of enzalutamide for the treatment of triple-negative breast cancer (TNBC). The... -
Sheraton grand debuts in London with designation of revamped sheraton park lane hotel
Jul 27, 2016News Hour: Sheraton Hotels & Resorts, part of Starwood Hotels & Resorts Worldwide, Inc.(NYSE:HOT), announced the designation of the Sheraton Grand London Park Lane, welcoming it to the brand’s premier tier of hotels recognised for their... -
Starwood hotels & resorts’ tech-forward aloft brand arrives in syracuse
Jul 27, 2016News Hour: Starwood Hotels & Resorts Worldwide, Inc.® announced its rapidly growing Aloft brand has made its debut in Syracuse, New York, within the new Inner Harbor waterfront development. Aloft Syracuse Inner Harbor features 132 spacious,... -
Shangri-la hotels and resorts announces kerry hotel, Hong Kong will open in december 2016
Jul 27, 2016News Hour: Shangri-La Hotels and Resorts announced it will open its fourth hotel in Hong Kong on Kowloon’s vibrant waterfront. Offering sweeping views of Victoria Harbour and the Hong Kong Island skyline, the 545-room Kerry Hotel,...
